Clinical Trials Logo

ALT clinical trials

View clinical trials related to ALT.

Filter by:
  • None
  • Page 1

NCT ID: NCT03740789 Active, not recruiting - Chronic Hepatitis b Clinical Trials

Evaluation of Antiviral Indications on Chronic HBV Infection With Different Transaminase Levels

Start date: October 24, 2018
Phase:
Study type: Observational

It remains unknown whether antiviral therapy is beneficial for chronic hepatitis B (CHB) with normal or mild ALT.The investigators aim to evaluate the antiviral indications combining liver biopsy and clinical parameters,and further clarify the response indexes of clinical results such as virological, serological, biochemical and histological responses from a retrospective observational cohort study on antiviral therapy in HBeAg positive and negative patients with different ALT levels,especially when ALT lower 2 times upper limit of normal (ULN).

NCT ID: NCT03073343 Recruiting - Clinical trials for Non-Alcoholic Fatty Liver Disease

A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

Start date: November 12, 2013
Phase: N/A
Study type: Interventional

Betaine (trimethyglycine) is a food supplement that is approved for sale in the United States without a prescription. In this study, betaine will be provided to patients as a powder that can be mixed with aqueous solutions and consumed orally.